Brazilian consumer products company Hypermarcas’ three latest acquisitions announced in mid-November are also good news for start-up boutique BR Partners.
The deals – R$85 million ($49.2 million) for soap brand Pom Pom, R$84 million for drug brands Diderat, Peridal and Lopigrel, and R$82.5 million for dental brand Bitufo – bring the number of M&A transactions that BR Partners has advised on to 14 this year, according to Dealogic. The firm is ranked fourth by number of deals.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
